OPSYNVI Film-coated tablet Ref.[109722] Active ingredients: Macitentan Tadalafil

Source: FDA, National Drug Code (US)  Revision Year: 2024 

Product description

OPSYNVI is a single tablet combination containing two oral components used to treat pulmonary arterial hypertension: macitentan, an endothelin receptor antagonist (ERA), and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor.

Macitentan

Macitentan is an endothelin receptor antagonist. The chemical name of macitentan is N-[5-(4-Bromophenyl)6[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide. It has a molecular formula of C19H20Br2N6O4S and a molecular weight of 588.27. Macitentan is achiral and has the following structural formula:

Macitentan is a crystalline powder that is insoluble in water. In the solid state macitentan is very stable, is not hygroscopic, and is not light sensitive.

Tadalafil

Tadalafil, an oral treatment for pulmonary arterial hypertension, is a selective inhibitor of cyclic guanosine monophosphate (cGMP)–specific phosphodiesterase type 5 (PDE5). Tadalafil has the empirical formula C22H19N3O4 representing a molecular weight of 389.41. The structural formula is:

The chemical designation is pyrazino[1ยด,2ยด:1,6]pyrido[3,4–b]indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-. It is a crystalline solid that is practically insoluble in water and very slightly soluble in ethanol.

OPSYNVI

OPSYNVI is available as 10 mg/20 mg macitentan/tadalafil and 10 mg/40 mg macitentan/tadalafil film-coated tablets for oral administration.

Each OPSYNVI core tablet contains the following inactive ingredients: Hydroxypropyl cellulose, hydroxypropyl cellulose (low-substituted), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polysorbate 80, povidone, sodium starch glycolate, sodium lauryl sulfate.

OPSYNVI 10 mg/20 mg tablets are film-coated with a coating material containing hydroxypropyl methylcellulose, iron oxide red, iron oxide yellow, lactose monohydrate, talc, titanium dioxide, and triacetin.

OPSYNVI 10 mg/40 mg tablets are film-coated with a coating material containing hydroxypropyl methylcellulose, lactose monohydrate, talc, titanium dioxide, and triacetin.

Dosage Forms and Strengths

OPSYNVI is available as:

10 mg/20 mg Pink Oblong Film-coated “1020” on one side and “MT” on the other side
10 mg/40 mg White to almost-white Oblong Film-coated “1040” on one side and “MT” on the other side
How Supplied

OPSYNVI (macitentan and tadalafil) tablets, 10 mg/20 mg, are supplied as pink, oblong film-coated tablets debossed with “1020” on one side and “MT” on the other side.

OPSYNVI 10 mg/20 mg is supplied as follows:

7-count bottles with child-resistant closure NDC 66215-812-07
7-count blister NDC 66215-812-08
30-count bottle with child-resistant closure NDC 66215-812-30

OPSYNVI (macitentan and tadalafil) tablets, 10 mg/40 mg, are supplied as white to almost-white, oblong film-coated tablets debossed with “1040” on one side and “MT” on the other side.

OPSYNVI 10 mg/40 mg is supplied as follows:

10-count blister NDC 66215-814-10
30-count bottle with child-resistant closure NDC 66215-814-30

Manufactured for: Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company, Titusville, NJ 08560, USA

Drugs

Drug Countries
OPSYNVI United States

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.